The World Health Organization (WHO) says it will discontinue the use of lopinavir/ritonavir, an AIDS treatment, in a clinical trial in Corona19.
WHO said it made the decision yesterday (4 days) in local time, accepting the recommendations of the International Steering Committee of the WHO Solidarity Experiment.
WHO explained that clinical trials of lopinavir/ritonavir in patients with corona19 in hospital showed little mortality compared to standard treatment.
WHO's solidarity experiments began as a study of the efficacy and safety of Corona19 treatments, divided into five categories.
The five divisions are standard therapy, ebdecirvir, an ebola treatment, hydroxychloroquine, a malaria drug, lopinavir/ritonavir, an AIDS drug, and lopinavir/ritonavir, combined with interferon.
The malaria drug, hydroxychloroquine, has also been discontinued in solidarity experiments because it has no specific efficacy.
WHO "AIDS drug treatment excluded from Corona 19 clinical trial"
2020-07-04T19:51:28.491Z
The World Health Organization says it will stop using AIDS drugs, lopinavir/ritonavir, in clinical trials in Corona19. WHO said it made the decision yesterday in local time, accepting the recommendations of the International Steering Committee of the WHO Solidarity Experiment.
Source: sbskr